Drugs / Seprafilm
Seprafilm
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT01594385 | Apr 2010 → Sep 2013 | — | Stan Stawicki | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Seprafilm | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01594385 ↗ |
| Known as | carboxymethylcellulose sodium hyaluronate adhesion barrier | “carboxymethylcellulose sodium hyaluronate adhesion barrier (CMHAB; Seprafilm, Genzyme Biosurgery, Bridgewater, NJ) on abdominal adhesions and wound characteristics in trauma...” PMID 24962185 ↗ Mar 2014 |
| Known as | CMHAB | “carboxymethylcellulose sodium hyaluronate adhesion barrier (CMHAB; Seprafilm, Genzyme Biosurgery, Bridgewater, NJ) on abdominal adhesions and wound characteristics in trauma...” PMID 24962185 ↗ Mar 2014 |